Hyp-dBET1
Hyp-dBET1 is a PROTAC degrader targeting BRD4. Hyp-dBET1 has an IC50 value of 3.4 μM in MDA-MB-231 cells. Hyp-dBET1 can be activated by hypoxia and recruit the E3 ubiquitin ligase and degrade BRD4 through ubiquitin-proteasome system. Hyp-dBET1 can be used for anti-tumor study[1].
Product Specifications
UNSPSC
12352005
Target
Epigenetic Reader Domain; PROTACs
Related Pathways
Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
CC1=C(C)C(C(C2=CC=C(Cl)C=C2)=N[C@H]3CC(N(CC4=CC=C([N+]([O-])=O)C=C4)CCCCNC(COC5=C6C(C(N(C7C(NC(CC7)=O)=O)C6=O)=O)=CC=C5)=O)=O)=C(S1)N8C3=NN=C8C
Molecular Formula
C45H42ClN9O9S
Molecular Weight
920.39
References & Citations
[1]Dutta R, et al. Dual-Action-Only PROTACs. J Am Chem Soc. 2025 Mar 19;147 (11) :9074-9078.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2632205 3x 1.0 µg
WDR43 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
bs-10159R-PE-Cy5.5 100 µL
PD-L1 Polyclonal Antibody, PE-Cy5.5 Conjugated
Sign In for Pricing
View Details MBS6193263-01 0.1 mL
Thioredoxin Reductase 2, Mitochondrial (TXNRD2, TRXR2, KIAA1652, Selenoprotein Z, SelZ, Thioredoxin Reductase TR3, TR-beta) (MaxLight 405)
Sign In for Pricing
View Details MBS6193263-02 5x 0.1 mL
Thioredoxin Reductase 2, Mitochondrial (TXNRD2, TRXR2, KIAA1652, Selenoprotein Z, SelZ, Thioredoxin Reductase TR3, TR-beta) (MaxLight 405)
Sign In for Pricing
View Details 